Literature DB >> 20573164

Relationship between formaldehyde and quaternium-15 contact allergy. Influence of strength of patch test reactions.

Anton C de Groot1, Janine Blok, Pieter-Jan Coenraads.   

Abstract

BACKGROUND: In groups of patients with formaldehyde allergy, many have positive patch tests to quaternium-15. Conversely, of patients allergic to quaternium-15, over half also react to formaldehyde.
OBJECTIVES: To test our hypothesis that patients with stronger patch test reactions to formaldehyde are more likely to react to quaternium-15, attesting to the aetiological role for formaldehyde in such co-reactivity.
METHODS: Retrospective analysis of all patients patch tested with formaldehyde and quaternium-15 in the European baseline series between 1994 and 2009 (TRUE test).
RESULTS: In a group of 86 patients allergic to formaldehyde, 73% co-reacted to quaternium-15; in the subgroup of 70 women, the percentage was 83. In both groups, more reactions were observed to quaternium-15 in the patients with a ++ reaction compared to the patients with a + reaction to formaldehyde. Conversely, stronger reactions to quaternium-15 were significantly more often associated with formaldehyde sensitivity in a group of 107 patients reacting to quaternium-15 and a subgroup of 88 women. In men, such effects were not observed and only 5 of 16 (31%) men allergic to formaldehyde also reacted to quaternium-15.
CONCLUSIONS: In women, but not in men, stronger reactions to formaldehyde lead to more positive quaternium-15 patch tests.
© 2010 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20573164     DOI: 10.1111/j.1600-0536.2010.01712.x

Source DB:  PubMed          Journal:  Contact Dermatitis        ISSN: 0105-1873            Impact factor:   6.600


  1 in total

1.  Patch test results in patients with allergic contact dermatitis in the Podlasie region.

Authors:  Teresa Reduta; Joanna Bacharewicz; Anna Pawłoś
Journal:  Postepy Dermatol Alergol       Date:  2013-12-18       Impact factor: 1.837

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.